BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hellesen A, Edvardsen K, Breivik L, Husebye ES, Bratland E. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease. Clin Exp Immunol 2014;176:351-62. [PMID: 24666275 DOI: 10.1111/cei.12291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Łukawska-tatarczuk M, Mrozikiewicz-rakowska B, Franek E, Czupryniak L. Rola autoimmunizacji w rozwoju powikłań cukrzycowych – przegląd badań. Postępy Higieny i Medycyny Doświadczalnej 2021;75:802-14. [DOI: 10.2478/ahem-2021-0043] [Reference Citation Analysis]
2 Hellesen A, Bratland E. The potential role for infections in the pathogenesis of autoimmune Addison's disease. Clin Exp Immunol 2019;195:52-63. [PMID: 30144040 DOI: 10.1111/cei.13207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
3 Hellesen A, Bratland E, Husebye ES. Autoimmune Addison's disease - An update on pathogenesis. Ann Endocrinol (Paris) 2018;79:157-63. [PMID: 29631795 DOI: 10.1016/j.ando.2018.03.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
4 Rosol TJ, Walling BE. Immunopathology of the Endocrine System. Immunopathology in Toxicology and Drug Development 2017. [DOI: 10.1007/978-3-319-47385-7_13] [Reference Citation Analysis]
5 Pazderska A, Fichna M, Mitchell AL, Napier CM, Gan E, Ruchała M, Santibanez-Koref M, Pearce SH. Impact of Month of Birth on the Risk of Development of Autoimmune Addison's Disease. J Clin Endocrinol Metab 2016;101:4214-8. [PMID: 27575942 DOI: 10.1210/jc.2016-2392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
6 Edvardsen K, Hellesen A, Husebye ES, Bratland E. Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. J Transl Med 2016;14:68. [PMID: 26956521 DOI: 10.1186/s12967-016-0822-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Fichna M, Żurawek M, Fichna P, Januszkiewicz-Lewandowska D, Ruchała M, Nowak J. Polymorphisms of the Toll-Like Receptor-3 Gene in Autoimmune Adrenal Failure and Type 1 Diabetes in Polish Patients. Arch Immunol Ther Exp (Warsz) 2016;64:83-7. [PMID: 26318769 DOI: 10.1007/s00005-015-0360-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
8 Edvardsen K, Bjånesøy T, Hellesen A, Breivik L, Bakke M, Husebye ES, Bratland E. Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines. J Interferon Cytokine Res 2015;35:759-70. [PMID: 25978633 DOI: 10.1089/jir.2014.0171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
9 Capobianchi MR, Uleri E, Caglioti C, Dolei A. Type I IFN family members: similarity, differences and interaction. Cytokine Growth Factor Rev 2015;26:103-11. [PMID: 25466633 DOI: 10.1016/j.cytogfr.2014.10.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]